Skip to main content
SpringerLink
Log in

A new LC-MS/MS bioanalytical method for perindopril and perindoprilat in human plasma and milk

  • Research Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

A first of its kind, simple, rapid, and sensitive liquid chromatography mass spectrometry (LC-MS/MS) method was developed and validated for quantification of perindopril and perindoprilat in both human plasma and breast milk. The analytes and internal standards (phenazone and acetyl salicylic acid) were extracted from biological matrices by protein precipitation. A Phenomenex® C-18 column was used to provide an appropriate chromatographic separation of the analytes, followed by detection with tandem mass spectrometry. Gradient chromatographic and mass spectrometric detection conditions with mobile phases (A: 5% methanol + 0.1% formic acid in water v/v, and B: 95% methanol + 0.1% formic acid in water v/v) were developed to achieve a LOQ of 0.5 ng/mL in both human plasma and milk. The method was suitable of evaluating clinical samples. The mass transition was followed as m/z 369.10/172.00 for perindopril, m/z 339.00/168.10 for perindoprilat, m/z 188.90/55.95 for phenazone, and m/z 179.04/137.02 for acetyl salicylic acid. The developed method was optimized and validated with a linear range of 0.1–200 ng/mL (r 2 = better than 0.99 for both perindopril and perindoprilat). The precision and accuracy values were within 15% CV. The overall recovery of the analytes was 80–110%. The method has good specificity and repeatability. Stability studies were conducted in both human plasma and bovine milk for up to 3 months, at the storage conditions of 25, 4, and −80 °C.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 9th ed. Philadelphia: Lippincott Williams & Wilkins, a Wolters Kluwer business; 2011.

    Google Scholar 

  2. Hale TW. Medications and mothers' milk. 15th ed. A manual of lactational pharmacology. USA: Hale Publishing, L.P; 2012.

    Google Scholar 

  3. Schaefer C, Peters P, Miller RK. Drugs during pregnancy and lactation. 2nd ed. USA: Elsevier; 2007.

    Google Scholar 

  4. Hale TW, Rowe HE. Medications & mothers' milk. 16th ed. The United States of America: Hale Publishing, L.P; 2014.

    Google Scholar 

  5. Coversyl [database on the Internet]. MIMS. 2012. Available from: https://www.mimsonline.com.au/Search/FullPI.aspx?ModuleName=Product%20Info&searchKeyword=coversyl&PreviousPage=~/Search/QuickSearch.aspx&SearchType=&ID=1490002_2. Accessed 6 May 2014.

  6. Coversyl (Perindopril Arginine) - Product Information. Therapeutic Goods Administration, Department of Health, Australian Government; 2012. p. 1-18.

  7. Hurst M, Jarvis B. Perindopril. Springer 2001;61(6):867–96.

  8. Nordeng H, Havnen GC, Spigset O. Drug use in breastfeeding. Review Article 2012;9(132):1089–93.

  9. Hale TW, Rowe HE. Medications & mothers' milk. 17th ed. New York: Springer, LLC; 2017.

    Google Scholar 

  10. British Pharmacopoeia (Ph. Eur. monograph 2019). Perindopril Erbumine. 2017.

  11. Jain DS, Subbaiah G, Sanyal M, Pande UC, Shrivastav P. First LC-MS/MS electrospray ionization validated method for the quantification of perindopril and its metabolite perindoprilat in human plasma and its application to equivalence study. J Chromatogr. 2006;837:92–100.

    CAS  Google Scholar 

  12. Nirogi RV, Kandikere VN, Shukla M, Mudigonda K, Maurya S, Komarneni P. High-throughput quantification of perindopril in human plasma by liquid chromatography/tandem mass spectrometry: application to a bioequivalence study. Rapid Commun Mass Spectrom. 2006;20(12):1864–70.

    Article  CAS  Google Scholar 

  13. Biopharmaceutics. Guidance for Industry: Bioanalytical Method Validation (Draft). USA: U.S. Department of Health and Human Servuces, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM); 2013.

  14. Lwin EMP, Gerber C, Song Y, Leggett C, Ritchie U, Turner S, et al. A new LC-MS/MS bioanalytical method for atenolol in human plasma and milk. Bioanalysis. 2017;9(7):517-30.

Download references

Acknowledgements

I would like to acknowledge the patient and clinicians at Women’s and Children’s Hospital, Adelaide, for supplying patient samples and blank human milk, Australian Red Cross for supplying blank human plasma, and Benjamin Tscharke and Ben Noll for their technical help.

Author information

Authors and Affiliations

  1. School of Pharmacy and Medical Sciences, University of South Australia, Reid Building, City East Campus, Adelaide, South Australia, 5000, Australia

    Ei Mon Phyo Lwin, Cobus Gerber, Yunmei Song & Sanjay Garg

  2. SA Pharmacy, Women’s and Children’s Hospital, 72 King William Road, Adelaide, South Australia, 5006, Australia

    Catherine Leggett, Usha Ritchie & Sean Turner

Authors
  1. Ei Mon Phyo Lwin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cobus Gerber
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yunmei Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Catherine Leggett
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Usha Ritchie
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sean Turner
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sanjay Garg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sanjay Garg.

Ethics declarations

Conflict of interest

This authors declare that there is no conflict of interest regarding the publication of this paper. The study was approved by the Women’s and Children’s Hospital Research Ethics Committee (HREC14/WCHN/115) and University of South Australia Research Ethics Committee (0000033979). Written informed consent was obtained from all participants.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Electronic supplementary material

ESM 1

(PDF 199 kb).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lwin, E.M.P., Gerber, C., Song, Y. et al. A new LC-MS/MS bioanalytical method for perindopril and perindoprilat in human plasma and milk. Anal Bioanal Chem 409, 6141–6148 (2017). https://doi.org/10.1007/s00216-017-0552-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-017-0552-y

Keywords

Search

Navigation